VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $838 | -69.6% | 89,451 | -24.4% | 0.01% | -68.8% |
| Q1 2023 | $2,753 | +1529.0% | 118,317 | +1675.7% | 0.03% | +1500.0% |
| Q4 2022 | $169 | -99.9% | 6,663 | -42.8% | 0.00% | -33.3% |
| Q3 2022 | $225,000 | -26.0% | 11,647 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $304,000 | -65.0% | 11,929 | -64.7% | 0.00% | -50.0% |
| Q1 2022 | $868,000 | +648.3% | 33,751 | +1115.8% | 0.01% | +500.0% |
| Q4 2021 | $116,000 | -95.6% | 2,776 | -95.4% | 0.00% | -91.7% |
| Q3 2021 | $2,617,000 | +50.8% | 60,131 | +63.8% | 0.01% | +50.0% |
| Q2 2021 | $1,735,000 | -19.3% | 36,704 | -12.5% | 0.01% | -27.3% |
| Q1 2021 | $2,150,000 | +248.5% | 41,927 | +81.9% | 0.01% | +266.7% |
| Q4 2020 | $617,000 | -38.8% | 23,051 | -6.4% | 0.00% | -62.5% |
| Q2 2020 | $1,008,000 | – | 24,614 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |